Europe Toxicity Testing Outsourcing Market Size, Share & Industry Trends Analysis Report by End-use, Method, GLP, Country and Growth Forecast, 2022-2028

The Europe Toxicity Testing Outsourcing Market would witness market growth of 8.3% CAGR during the forecast period (2022-2028).

Testing for toxicity can show whether or not toxins are bioavailable. A contaminant's existence does not automatically suggest that it will have negative effects. An organism's body covering may occasionally be harmed by the presence of granules, such as the talcum in insecticides, which increases the bioavailability of some pollutants for that organism.

The cumulative harmful effects of all pollutants in a medium can be assessed through toxicity testing. A complex assortment of contaminants can be found at many sites, and the media often contains a variety of potentially dangerous compounds. Chemical information alone cannot reliably forecast the toxicity of the pollutants at such places. Instead, toxicity tests assess the overall impact of polluted media on living things.

These effects are a result of interactions among contaminants, properties of the means itself, and interaction between contaminants and media. As a result, observed toxicity test findings may frequently differ from those expected based solely on chemical data. The toxicity of drugs whose biological functions may have not been adequately documented can be assessed via toxicity tests.

In vitro testing is prioritized over animal testing in European techniques to enhance toxicity testing. The development of in vitro devices that can forecast the results of concentrated dose testing in animals, however, is a key objective of the European approaches. In vitro research holds the promise of supplying additional mechanistic details and enabling thorough and quick analyses of biological changes that are directly related to human exposures and biology.

The Germany market dominated the Europe Toxicity Testing Outsourcing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $334.5 million by 2028.The UK market is anticipated to grow at a CAGR of 7.4% during (2022-2028). Additionally, The France market would exhibit a CAGR of 9% during (2022-2028).

Based on End Use, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic & Research Institutes and Others. Based on Method, the market is segmented into In Vitro and In Vivo. Based on GLP, the market is segmented into GLP and Non-GLP. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific Group, WuXi AppTec Co., Ltd., SGS S.A., Intertek Group PLC, Catalent, Inc., Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., ICON PLC, and Medpace Holdings, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End Use

• Pharmaceutical & Biopharmaceutical Companies
• Academic & Research Institutes
• Others

By Method

• In Vitro
• In Vivo

By GLP

• GLP
• Non-GLP

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Thermo Fisher Scientific, Inc.
• Eurofins Scientific Group
• WuXi AppTec Co., Ltd.
• SGS S.A.
• Intertek Group PLC
• Catalent, Inc.
• Laboratory Corporation of America Holdings
• Charles River Laboratories International, Inc.
• ICON PLC
• Medpace Holdings, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free